1.
Negrini C, Psachoulia E. Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets. Farmeconomia. Health Economics and Therapeutic Pathways. 2017;18(1). https://doi.org/10.7175/fe.v18i1.1330